Chakravarthy, U., Harding, S., Rogers, C., Downes, S., Lotery, A., Wordsworth, S., & Reeves, B. (2012). Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration.
Style de citation Chicago (17e éd.)Chakravarthy, U., S. Harding, C. Rogers, S. Downes, A. Lotery, S. Wordsworth, et B. Reeves. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.
Style de citation MLA (9e éd.)Chakravarthy, U., et al. Ranibizumab Versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration. 2012.
Attention : ces citations peuvent ne pas être correctes à 100%.